Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Domest Anim Endocrinol ; 75: 106595, 2021 04.
Article in English | MEDLINE | ID: mdl-33307335

ABSTRACT

Insulin glargine (IGla) is a synthetic human-recombinant insulin analog that is used routinely in people as a q24h basal insulin. The 300 U/mL (U300) formulation of IGla is associated with longer duration of action and less within-day variability, making it a better basal insulin compared with the 100 U/mL (U100) formulation. We hypothesized that in healthy cats, IGlaU300 has a flatter time-action profile and longer duration of action compared with IGlaU100. Seven healthy neutered male, purpose-bred cats were studied in a randomized, crossover design. Pharmacodynamics of IGlaU100 and IGlaU300 (0.8 U/kg, subcutaneous) were determined by the isoglycemic clamp method. The time-action profile of IGlaU300 was flatter compared with IGlaU100 as demonstrated by lower peak (5.6 ± 1.1 mg/kg/min vs 8.3 ± 1.9 mg/kg/min, respectively; P = 0.04) with no difference in total metabolic effect (ME; P = 0.7) or duration of action (16.8 h ± 4.7 h vs 13.4 h ± 2.6 h; P = 0.2). The greater fraction of ME in the 12- to 24-h period postinjection (35 ± 23% vs 7 ± 8% respectively; P = 0.048) and lower intraday GIR% variability (7.8 ± 3.7% vs 17.4 ± 8.2% respectively; P = 0.03) supports a flatter time-action profile of IGlaU300. There were no differences in onset and end of the action. In summary, although both formulations have a similar duration of action that is well below 24 h, the ME of IGlaU300 is more evenly distributed over a 24 h period in healthy cats, making it a better candidate for once-daily injection in diabetics compared with IGlaU100.


Subject(s)
Hypoglycemic Agents , Insulin, Long-Acting , Animals , Blood Glucose/metabolism , Cats , Cross-Over Studies , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Insulin Glargine/pharmacology , Insulin, Long-Acting/pharmacology , Male
2.
Domest Anim Endocrinol ; 74: 106484, 2021 01.
Article in English | MEDLINE | ID: mdl-32619812

ABSTRACT

Somatostatin secretion from islet delta cells is important in maintaining low glycemic variability (GV) by providing negative feedback to beta cells and inhibiting insulin secretion. Capromorelin is a ghrelin-receptor agonist that activates the growth hormone secretagogue receptor on delta cells. We hypothesized that in cats, capromorelin administration will result in decreased GV at the expense of reduced insulin secretion and glucose tolerance. Seven healthy cats were treated with capromorelin from days 1-30. After the first day, fasting blood glucose increased (+13 ± 3 mg/dL, P < 0.0001), insulin decreased (+128 ± 122 ng/dL, P = 0.03), and glucagon was unchanged. Blood glucose was increased throughout an intravenous glucose tolerance test on day 1 with blunting of first-phase insulin response ([FPIR] 4,931 ± 2,597 ng/L/15 min) compared with day -3 (17,437 ± 8,302 ng/L/15 min, P = 0.004). On day 30, FPIR was still blunted (9,993 ± 4,285 ng/L/15 min, P = 0.045), but glucose tolerance returned to baseline. Mean interstitial glucose was increased (+19 ± 6 mg/dL, P = 0.03) on days 2-4 but returned to baseline by days 27-29 (P = 0.3). On days 2-4, GV was increased (SD = 9.7 ± 3.2) compared with baseline (SD = 5.0 ± 1.1, P = 0.02) and returned to baseline on days 27-29 (SD = 6.1 ± 1.1, P = 0.16). In summary, capromorelin caused a decline in insulin secretion and glycemic control and an increase in glucose variability early in the course of treatment, but these effects diminished toward the end of 30 d of treatment.


Subject(s)
Cats/metabolism , Glucose/metabolism , Piperidines/pharmacology , Pyrazoles/pharmacology , Receptors, Ghrelin/agonists , Animals , Blood Glucose , Cats/blood , Glucagon/blood , Glucose Tolerance Test/veterinary , Insulin/blood , Insulin Resistance , Male
3.
Transbound Emerg Dis ; 62(5): e71-5, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24325543

ABSTRACT

In high-density farming practices, it is important to constantly monitor for infectious diseases, especially diseases that have the potential to spread rapidly between holdings. Pigs are known to amplify foot-and-mouth disease (FMD) by excreting large amounts of virus, and it is therefore important to detect the virus quickly and accurately to minimize the spread of disease. Ropes were used to collect oral fluid samples from pigs, and each sample was compared to saliva samples collected from individual animals by detecting FMD virus RNA using real-time PCR. Two different experiments are described where groups of pigs were infected with different serotypes of FMD virus, either with or without vaccination, and unvaccinated pigs were kept in aerosol contact. The sensitivity of the rope sampling varied between 0.67 and 0.92, and the statistical agreement between this method and individual sampling ranged from substantial to moderate for the two different serotypes. The ease of collecting oral fluids using ropes together with the high sensitivity of subsequent FMD detection through PCR indicates that this could be a useful method to monitor pig populations for FMD virus infection. With further validation of the sensitivity of detection of FMD virus RNA, this can be a cost-effective, non-invasive diagnostic tool.


Subject(s)
Foot-and-Mouth Disease Virus/isolation & purification , Foot-and-Mouth Disease/diagnosis , Specimen Handling/veterinary , Animals , Foot-and-Mouth Disease/prevention & control , Foot-and-Mouth Disease/virology , Foot-and-Mouth Disease Virus/genetics , Foot-and-Mouth Disease Virus/pathogenicity , Real-Time Polymerase Chain Reaction/veterinary , Saliva/virology , Specimen Handling/methods , Swine , Vaccination/veterinary , Viral Load
4.
Mol Pharm ; 11(10): 3443-51, 2014 Oct 06.
Article in English | MEDLINE | ID: mdl-25189995

ABSTRACT

The M-type phospholipase A2 receptor (PLA2R1) is a member of the C-type lectin superfamily and can internalize secreted phospholipase A2 (sPLA2) via endocytosis in non-cancer cells. sPLA2 itself was recently shown to be overexpressed in prostate tumors and to be a possible mediator of metastasis; however, little is known about the expression of PLA2R1 or its function in prostate cancers. Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics. Immunoblot analysis demonstrated that the expression of PLA2R1 was higher in prostate cancer cells compared to that in primary prostate cells. Knockdown of PLA2R1 expression in PC-3 cells using shRNA increased cell proliferation and did not affect the toxicity of cisplatin, doxorubicin (Dox), and docetaxel. In contrast, PLA2R1 knockdown increased the in vitro toxicity of Dox encapsulated in sPLA2 responsive liposomes (SPRL) and correlated with increased Dox and SPRL uptake. Knockdown of PLA2R1 also increased the expression of Group IIA and X sPLA2. These data show the novel findings that PLA2R1 is expressed in prostate cancer cells, that PLA2R1 expression alters cell proliferation, and that PLA2R1 modulates the behavior of liposome-based nanoparticles. Furthermore, these studies suggest that PLA2R1 may represent a novel molecular target for controlling tumor growth or modulating delivery of lipid-based nanomedicines.


Subject(s)
Drug Delivery Systems/methods , Liposomes/administration & dosage , Prostatic Neoplasms/enzymology , Receptors, Phospholipase A2/metabolism , Blotting, Western , Cell Line, Tumor , Humans , Male , Nanoparticles/chemistry , Receptors, Phospholipase A2/genetics , Tumor Cells, Cultured
5.
Biopolymers ; 58(2): 204-17, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11093119

ABSTRACT

The supercoiling free energy of pUC19 DNA [2686 base pairs (bp)] was measured in various concentrations of PEG 8000 (polyethylene glycol; molecular weight 8000) by the topoisomer distribution method. The effective twist energy parameter (E(T)) that governs the supercoiling free energy declined linearly by 1.9-fold with increasing w/v % PEG from 0 to 7.5%, which lies below the threshold for intermolecular condensation. In principle, PEG could affect E(T) either via an osmotic exclusion mechanism or by altering the torsion elastic constant, bending rigidity, or self-repulsions of the DNA. Possible alterations of the DNA secondary structure and torsion elastic constant were assessed by CD spectroscopy and time-resolved fluorescence polarization anisotropy of intercalated ethidium. Up to 7.5% PEG, the secondary structure of the DNA remained largely unaltered, as evidenced by (1) the absence of any significant change in the CD spectrum, (2) an extremely small relative decrease (-0.0013) in intrinsic twist, and (3) a negligibly small change in the torsion elastic constant. The observed reduction in E(T) cannot be ascribed primarily to a decrease in torsion elastic constant, and most likely does not stem from a decrease in bending rigidity either. The decrease in medium dielectric constant due to PEG should increase the self-repulsions, and thereby increase E(T), which is opposite to the observed trend. Instead, the observed decline in E(T) is attributed to an osmotic exclusion mechanism. The change in molar volume excluded to the PEG (Delta V(ex)), when the linking difference converts from Delta l = 0 to Delta l = +/-1, was determined from the observed E(T) value and PEG osmotic pressure at each concentration. The experimental Delta V(ex) values agree well with theoretical estimates reckoned for a simple osmotic exclusion model, in which PEG is excluded by hard-core interactions from a concentric cylindrical volume around every duplex segment. The difference in volume excluded to PEG between the Delta l = 0 and the Delta l = +/-1 topoisomers is attributed entirely to the approximately 0.7 additional writhe "crossing" of two duplex strands at roughly 90 degrees, which is known to occur in the latter species. When the separation between the duplex centers at the "crossing" was adjusted so that the theoretical estimate of Delta V(ex) matched the experimental value at each PEG concentration, a value near 5.7 nm was obtained in each case. The invariance and plausible magnitude of this mean separation at the crossing provide strong support for this simple osmotic exclusion model. An alternative model, in which the PEG is excluded from the entire coil envelope of the DNA out to its radius of gyration, perhaps because it decreases the local dielectric constant, was also considered. The estimated difference in excluded volume in that case exceeds the experimental value by a factor of nearly 10(4), and could be ruled out on that basis.


Subject(s)
DNA, Superhelical/chemistry , Circular Dichroism , DNA, Bacterial/chemistry , Nucleic Acid Conformation , Plasmids/chemistry , Polyethylene Glycols , Thermodynamics
6.
J Am Mosq Control Assoc ; 6(3): 500-3, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2230780

ABSTRACT

A study of laboratory and field reared 2nd and 3rd instar Culex pipiens larvae suggests that extracts from 2 varieties of Sorghum bicolor seedlings are significant (P less than 0.05) larvicides under laboratory conditions. These plant extracts contain the organic cyanogen dhurrin and were calibrated to produce 90% mortality in 2nd instar Culex pipiens larvae at 0.82 ppm and 90% mortality in 3rd instar larvae at 1.12 ppm. A preliminary behavioral assessment of late 3rd instar larvae exposed to 1.42 ppm suggests that these plant extracts produce 80% mortality after only 4-5 h of contact. Plant extracts appear stable when stored at up to 32 degrees C in a closed container. Once the extracts are infused in water and exposed to air, however, they biodegrade after 24 h. These laboratory results emphasize the need for field tests against natural populations of Culex pipiens and nontarget organisms.


Subject(s)
Culex , Edible Grain , Mosquito Control/methods , Animals , Larva , Plant Extracts
SELECTION OF CITATIONS
SEARCH DETAIL
...